Middle East Pharmaceutical Industries Company (TADAWUL:4016)
121.10
+0.10 (0.08%)
Jul 3, 2025, 3:16 PM AST
TADAWUL:4016 Balance Sheet
Financials in millions SAR. Fiscal year is January - December.
Millions SAR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Cash & Equivalents | 33.87 | 22.65 | 15.11 | 23.79 | 19.04 | 15.92 |
Cash & Short-Term Investments | 33.87 | 22.65 | 15.11 | 23.79 | 19.04 | 15.92 |
Cash Growth | -1.92% | 49.90% | -36.50% | 24.98% | 19.54% | - |
Accounts Receivable | 222.89 | 217.48 | 163.37 | 151.57 | 164.37 | 109.86 |
Other Receivables | 5.2 | 8.01 | 2.16 | 3.15 | 2.68 | 2.66 |
Receivables | 228.09 | 225.49 | 165.52 | 154.73 | 167.05 | 112.53 |
Inventory | 94.65 | 93.6 | 87.17 | 100.21 | 74.45 | 82.51 |
Prepaid Expenses | 4.71 | 3.31 | 2.74 | 3.41 | 3.26 | 3.45 |
Other Current Assets | 12.41 | 10.38 | 14.95 | 9.36 | 5.57 | 10.79 |
Total Current Assets | 373.72 | 355.42 | 285.49 | 291.5 | 269.37 | 225.2 |
Property, Plant & Equipment | 122.62 | 120.76 | 119.08 | 105.86 | 103.45 | 94.72 |
Long-Term Investments | - | - | 1.32 | 3.61 | 9.82 | 22.72 |
Other Intangible Assets | 51.99 | 50.59 | 46.85 | 41.49 | 34.29 | 27.99 |
Total Assets | 548.33 | 526.78 | 452.74 | 442.45 | 416.93 | 370.63 |
Accounts Payable | 38.1 | 27.35 | 28.04 | 37.95 | 32.73 | 26.2 |
Accrued Expenses | 15.18 | 24.22 | 16.58 | 10.91 | 7.31 | 10.06 |
Short-Term Debt | 60.86 | 62.31 | 52.5 | 69.13 | 66.44 | 42.05 |
Current Portion of Long-Term Debt | 1.58 | 3.17 | 6.34 | 6.34 | 4.75 | - |
Current Income Taxes Payable | 8.63 | 7.09 | 5.43 | 5.59 | 4.79 | 5.18 |
Other Current Liabilities | 11.4 | 9.89 | 12.2 | 1.68 | 1.37 | 1.26 |
Total Current Liabilities | 135.75 | 134.04 | 121.08 | 131.59 | 117.39 | 84.76 |
Long-Term Debt | - | - | 3.17 | 9.51 | 15.84 | 20.6 |
Total Liabilities | 160.73 | 158.57 | 146.35 | 162.18 | 149.85 | 118.2 |
Common Stock | 200 | 200 | 200 | 200 | 60 | 60 |
Retained Earnings | 199.36 | 179.96 | 133.07 | 104.63 | 221.53 | 192.45 |
Comprehensive Income & Other | -11.75 | -11.75 | -26.67 | -24.36 | -14.45 | -0.02 |
Shareholders' Equity | 387.61 | 368.21 | 306.4 | 280.27 | 267.08 | 252.43 |
Total Liabilities & Equity | 548.33 | 526.78 | 452.74 | 442.45 | 416.93 | 370.63 |
Total Debt | 62.45 | 65.48 | 62 | 84.97 | 87.04 | 62.65 |
Net Cash (Debt) | -28.58 | -42.83 | -46.9 | -61.18 | -68 | -46.73 |
Net Cash Per Share | -1.43 | -2.14 | -2.34 | -3.06 | -3.40 | -2.34 |
Filing Date Shares Outstanding | 20 | 20 | 20 | 20 | 20 | 20 |
Total Common Shares Outstanding | 20 | 20 | 20 | 20 | 20 | 20 |
Working Capital | 237.97 | 221.39 | 164.41 | 159.91 | 151.98 | 140.43 |
Book Value Per Share | 19.38 | 18.41 | 15.32 | 14.01 | 13.35 | 12.62 |
Tangible Book Value | 335.62 | 317.62 | 259.55 | 238.79 | 232.79 | 224.44 |
Tangible Book Value Per Share | 16.78 | 15.88 | 12.98 | 11.94 | 11.64 | 11.22 |
Land | 15.83 | 15.83 | 15.83 | 10.19 | 10.19 | 10.19 |
Buildings | 96.36 | 96.36 | 89.12 | 86.53 | 54.19 | 54.15 |
Machinery | 84.46 | 84.29 | 61.65 | 56.99 | 52.95 | 56.86 |
Construction In Progress | 9.39 | 4.9 | 24.99 | 17.33 | 46 | 26.94 |
Updated Nov 11, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.